<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38534">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01956422</url>
  </required_header>
  <id_info>
    <org_study_id>CE#382/2013</org_study_id>
    <nct_id>NCT01956422</nct_id>
  </id_info>
  <brief_title>Continuous Positive Airway Pressure (CPAP) for Preventing Respiratory Failure After Laparoscopic Radical Prostatectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale L. Sacco – Polo Universitario</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale L. Sacco – Polo Universitario</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this study is verify if postoperative CPAP after laparoscopic prostatectomy may
      reduce the impact of postoperative respiratory failure, defined as occurrence of hypoxemia
      (PaO2&lt;60 mmHg) and/or reduction of Forced Expiratory Volume in 1 second (FEV1) beyond 70% of
      basal value.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Laparoscopic radical prostatectomy (LRP) is a wide used, well tolerated procedure. However,
      the general anesthesia, the need for pneumoperitoneum and Trendelenburg position may have
      detrimental effects on both pulmonary volumes and mechanics, and they may  increase the risk
      of postoperative respiratory failure (PORF). Continuous positive airway pressure (CPAP)
      improves oxygenation and reduces the rate of re-intubation in the presence of PORF.

      The aim of our study is to  investigate postoperative respiratory function and the likely
      benefits of the use of CPAP, compared with  Venturi mask in terms of prevention of
      post-operative hypoxaemia and worsening of lung spirometry.

      CPAP is delivered with &quot;CASTAR&quot; Helmet by StarMed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Incidence of postoperative respiratory failure (PaO2&lt;60mmHg, FEV1&lt;70% of baseline)</measure>
    <time_frame>24 hours after the end of surgery</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of pneumonia</measure>
    <time_frame>Partecipants will be followed for the duration of hospital stay, an expected average of 1 week</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Continuous Positive Airway Pressure [E02.041.625.790.259]</condition>
  <condition>Prostatectomy [E04.950.774.860.625]</condition>
  <condition>Laparoscopy [E01.370.388.250.520]</condition>
  <condition>Pneumoperitoneum [C06.844.670]</condition>
  <arm_group>
    <arm_group_label>Continuous Positive Airway Pressure(CPAP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the first 24 hours after laparoscopic prostatectomy patients undergo 3 CPAP cycles (PEEP 7.5, FIO2 40% delivered with Helmet)lasting 2 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Venturi Mask FiO2 40%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the first 24 hours after laparoscopic prostatectomy patients breathe Oxygen 40% delivered with Venturi Mask</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous Positive Airway Pressure(CPAP)</intervention_name>
    <arm_group_label>Continuous Positive Airway Pressure(CPAP)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Venturi Mask FiO2 40%</intervention_name>
    <arm_group_label>Venturi Mask FiO2 40%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for elective laparoscopic prostatectomy

          -  American Society of Anesthesiologists status I-II

        Exclusion Criteria:

          -  Cardiac functional status New York Heart Association (NYHA) &gt;II

          -  Chronic Obstructive Pulmonary Disease (COPD) Gold Class &gt;2
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tommaso Fossali, Consultant</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale L. Sacco – Polo Universitario</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale Luigi Sacco</name>
      <address>
        <city>Milano</city>
        <state>Lombardia</state>
        <zip>20157</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tommaso Fossali, Consultant</last_name>
      <phone>+390239043023</phone>
      <email>fossali.tommaso@hsacco.it</email>
    </contact>
    <investigator>
      <last_name>Tommaso Fossali, Consultant</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Ferreyra GP, Baussano I, Squadrone V, Richiardi L, Marchiaro G, Del Sorbo L, Mascia L, Merletti F, Ranieri VM. Continuous positive airway pressure for treatment of respiratory complications after abdominal surgery: a systematic review and meta-analysis. Ann Surg. 2008 Apr;247(4):617-26. Review.</citation>
    <PMID>18362624</PMID>
  </reference>
  <reference>
    <citation>Squadrone V, Coha M, Cerutti E, Schellino MM, Biolino P, Occella P, Belloni G, Vilianis G, Fiore G, Cavallo F, Ranieri VM; Piedmont Intensive Care Units Network (PICUN). Continuous positive airway pressure for treatment of postoperative hypoxemia: a randomized controlled trial. JAMA. 2005 Feb 2;293(5):589-95. PubMed PMID: 15687314.</citation>
    <PMID>15687314</PMID>
  </reference>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 6, 2013</lastchanged_date>
  <firstreceived_date>September 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale L. Sacco - Polo Universitario</investigator_affiliation>
    <investigator_full_name>Tommaso Fossali</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pneumoperitoneum</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
